Literature DB >> 22736561

Paroxetine and neonatal withdrawal syndrome.

Laura Pogliani1, Laura Schneider, Dario Dilillo, Francesca Penagini, Gian Vincenzo Zuccotti.   

Abstract

We report a case of neonatal withdrawal syndrome after in utero exposure to paroxetine 20 mg/day. The infant's symptoms, such as poor neonatal adaptation, respiratory distress, decerebrate posturing, irritability and tremors, commenced soon after birth and persisted for 5 days. All neonates exposed to antidepressants, particularly serotonin reuptake inhibitors (SSRIs), during the last trimester should be followed-up closely for adverse symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22736561      PMCID: PMC3047551          DOI: 10.1136/bcr.12.2009.2528

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

Authors:  G K Isbister; A Dawson; I M Whyte; F H Prior; C Clancy; A J Smith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

2.  Neonate characteristics after maternal use of antidepressants in late pregnancy.

Authors:  Bengt Källén
Journal:  Arch Pediatr Adolesc Med       Date:  2004-04

3.  Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.

Authors:  Emilio J Sanz; Carlos De-las-Cuevas; Anne Kiuru; Andrew Bate; Ralph Edwards
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321

4.  Perinatal outcome following third trimester exposure to paroxetine.

Authors:  Adriana Moldovan Costei; Eran Kozer; Tommy Ho; Shinya Ito; Gideon Koren
Journal:  Arch Pediatr Adolesc Med       Date:  2002-11

Review 5.  Perinatal risks of untreated depression during pregnancy.

Authors:  Lori Bonari; Natasha Pinto; Eric Ahn; Adrienne Einarson; Meir Steiner; Gideon Koren
Journal:  Can J Psychiatry       Date:  2004-11       Impact factor: 4.356

6.  Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Authors:  Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

7.  Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.

Authors:  Brian Chun-Fai-Chan; Gideon Koren; Ibrahim Fayez; Sanjog Kalra; Sharon Voyer-Lavigne; Andrew Boshier; Saad Shakir; Adrienne Einarson
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

8.  Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Authors:  Christina D Chambers; Sonia Hernandez-Diaz; Linda J Van Marter; Martha M Werler; Carol Louik; Kenneth Lyons Jones; Allen A Mitchell
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

9.  Birth outcomes in pregnant women taking fluoxetine.

Authors:  C D Chambers; K A Johnson; L M Dick; R J Felix; K L Jones
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

10.  Birth outcomes after prenatal exposure to antidepressant medication.

Authors:  Victoria Hendrick; Lynne M Smith; Rita Suri; Sun Hwang; Desiree Haynes; Lori Altshuler
Journal:  Am J Obstet Gynecol       Date:  2003-03       Impact factor: 8.661

View more
  2 in total

Review 1.  Infant Colic.

Authors:  Amy A Gelfand
Journal:  Semin Pediatr Neurol       Date:  2015-08-17       Impact factor: 1.636

Review 2.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.